Clomiphene, enclomiphene or hCG: raising testosterone without TRT
Yes. Clomiphene citrate and enclomiphene, which are oral selective estrogen receptor modulators (SERMs), and hCG (human chorionic gonadotropin), an injection that acts like the hormone that tells your testes to work, can raise your own testosterone instead of replacing it. They only help if your testes can still respond to a signal, so the best candidates are men with secondary hypogonadism or men who want to keep their fertility. None of them is a shortcut: clomiphene is used off-label in men, enclomiphene is not FDA-approved, and hCG must come from an FDA-approved product.
This is the middle option between lifestyle changes and testosterone replacement therapy (TRT), and it is the one most answers skip. Here is how each drug works, what the evidence supports, and how to tell whether you are a candidate.
TRT replaces testosterone. These drugs restart your own
Your testosterone runs on a feedback loop. The hypothalamus releases GnRH, the pituitary answers with luteinizing hormone (LH) and follicle stimulating hormone (FSH), and those two signals tell your testes to make testosterone and sperm.
TRT supplies testosterone from outside. Your brain senses it, turns LH and FSH down, and your testes make less of their own testosterone and fewer sperm. That is why the Endocrine Society guideline recommends against testosterone therapy in men planning fertility in the near term, and the AUA guideline states that exogenous testosterone should not be prescribed to men who are currently trying to conceive.
SERMs and hCG work from the other direction:
- SERMs (clomiphene, enclomiphene) block estrogen's feedback at the hypothalamus and pituitary. Your brain reads that as a shortage, raises LH and FSH, and your testes make more testosterone while continuing to make sperm.
- hCG skips the brain and binds the LH receptor on the testes directly, telling them to produce testosterone.
Who is a candidate. Diagnosis comes first. Both guidelines call for symptoms plus consistently low testosterone on more than one early morning blood draw. The AUA uses a total testosterone below 300 ng/dL on two separate early morning measurements as a reasonable cutoff. LH and FSH then tell you where the problem sits. Low testosterone with low or normal LH points to secondary hypogonadism (a signaling problem). Low testosterone with high LH points to primary hypogonadism (a testicular problem). The AUA also recommends checking prolactin when testosterone is low and LH is low or low normal, because a pituitary problem needs its own workup.
The men most likely to benefit:
- Secondary hypogonadism, often linked to obesity, poor sleep, certain medications or past anabolic steroid use
- Men who want children now or in the next few years
- Younger men who would rather not commit to lifelong TRT
Before any prescription, the Endocrine Society guideline advises looking for reversible causes. Excess weight, untreated sleep apnea, heavy alcohol use and drugs such as opioids or glucocorticoids can all lower testosterone, and losing weight can raise it in men with obesity. Over-the-counter "testosterone boosters" are a different story: the evidence that they meaningfully raise testosterone is weak.
Clomiphene citrate: the long-standing off-label option
Clomiphene's FDA label covers ovulatory dysfunction in women. In men it is prescribed off-label, which is legal and common, but it means the FDA has not reviewed it for this use.
Clomiphene is a mix of two isomers. Enclomiphene is the part that blocks estrogen feedback and drives LH up. Zuclomiphene is weakly estrogenic, has a much longer half-life and can build up in the body over time.
Evidence. Studies in men with secondary hypogonadism, mostly observational or small randomized trials, consistently show rises in LH and total testosterone. Improvement in symptoms such as energy and libido is less consistent, and long-term safety data are limited. The AUA guideline lists SERMs among the options clinicians can use in men with testosterone deficiency who want to maintain fertility.
Side effects. The clomiphene label warns about visual symptoms, including blurring, spots and flashes of light, and says the drug should be stopped and the eyes evaluated if they occur. Men also report mood changes, irritability, headaches and breast tenderness. Because more testosterone means more conversion to estradiol, estradiol usually rises too, which is one reason labs are rechecked after starting.
Enclomiphene: the purified isomer, still not FDA-approved
Enclomiphene is the trans isomer of clomiphene on its own. The idea is simple: keep the LH boost and drop zuclomiphene, the slower, estrogen-like component.
A drug company pursued FDA approval of enclomiphene for secondary hypogonadism in the 2010s, and the FDA did not approve it. Company-sponsored trials reported higher testosterone with sperm counts preserved, but without approval there is no FDA-reviewed label, dosing or safety summary to rely on.
In 2026 there is still no FDA-approved enclomiphene product in the United States. It has reached patients mainly through compounding pharmacies and telehealth companies, and its legal status for compounding has been contested and reviewed by regulators. In practice, that means:
- Quality depends on the pharmacy that makes it
- Availability can change with regulatory decisions
- Insurance will not cover it
If you are offered enclomiphene, ask which pharmacy is dispensing it and on what legal basis. A careful prescriber will answer that plainly and will also discuss clomiphene, which has an FDA-approved product behind it.
hCG: FDA-approved, injectable and no longer compounded
The chorionic gonadotropin label includes selected cases of hypogonadotropic hypogonadism in males, prepubertal cryptorchidism and ovulation induction. Of the three drugs here, hCG is the only one with an FDA-labeled use for low testosterone in men. The same label states that hCG has not been shown to be effective for obesity, so weight loss is not a legitimate reason to use it.
Fertility. hCG supports testosterone production inside the testes, which sperm production depends on. The AUA guideline includes hCG among options for men with testosterone deficiency who want to maintain fertility. Some physicians also use it alongside TRT to limit testicular shrinkage, which is an off-label use.
Supply and compounding. Since March 2020, hCG has been regulated as a biological product. Compounding pharmacies generally cannot compound biologics, so patients now need an FDA-approved brand or generic product. Supply interruptions have occurred, which can affect timing.
Side effects. Expect possible rises in estradiol, breast tenderness or enlargement, headache, irritability, fatigue, fluid retention and injection site soreness. It is injected on a schedule your physician sets, usually more than once a week.
Side-by-side comparison
| Option | How it works | Effect on your own testosterone | Fertility | Regulatory status (US, 2026) | How pricing works | Monitoring |
|---|---|---|---|---|---|---|
| TRT (e.g., testosterone cypionate) | Replaces testosterone from outside | Suppresses natural production | Lowers sperm production | FDA-approved for hypogonadism | Generic injectable plus ongoing labs and visits | Testosterone, hematocrit, PSA when indicated |
| Clomiphene citrate | Blocks estrogen feedback, raises LH and FSH | Raises it if the axis is intact | Generally preserved | FDA-approved for women; off-label in men | Generic oral tablet; off-label use may not be covered | Testosterone, estradiol, LH; report vision changes |
| Enclomiphene | Purified clomiphene isomer, same mechanism | Raises it if the axis is intact | Generally preserved | Not FDA-approved; compounded supply only | Cash-pay compounded product | Testosterone, estradiol, LH |
| hCG | Mimics LH at the testes | Raises it directly | Supports sperm production | FDA-approved; no compounded versions | FDA-approved brand or generic injectable, often the costliest of the three | Testosterone, estradiol, hematocrit |
For men on TRT, the Endocrine Society guideline recommends checking hematocrit and pausing therapy if it rises above 54%. Hematocrit can climb on the other options too, so it belongs on every follow-up panel. If fertility is the goal, a semen analysis tells you more than a testosterone number. And remember: a higher lab value does not guarantee you will feel different. Long-term trials comparing these drugs head to head with TRT for symptom relief are lacking.
When these don't work: primary hypogonadism
SERMs and hCG depend on testes that can still respond. In primary hypogonadism, the testes themselves are the problem. Causes include Klinefelter syndrome, mumps orchitis, chemotherapy or radiation, testicular injury and a history of undescended testes. In these men LH and FSH are already high, so more signal adds little.
TRT is the standard treatment for symptomatic primary hypogonadism. If you might want children, talk to a reproductive urologist before starting it, because sperm banking or other steps are easier to plan beforehand.
The same applies if you try a SERM or hCG and your testosterone or symptoms do not improve on follow-up labs. That is a reason to reassess the diagnosis, not to keep raising the dose.
Where BioCure fits
BioCure Health offers three testosterone tiers. Our bioRestore tier uses medications that raise your body's own testosterone without direct hormone replacement, built for men whose labs and goals point to this middle path. The specific medication in a bioRestore protocol is chosen by your physician based on your labs and discussed with you in your results review. For men who need full replacement, bioTest provides TRT with ongoing hormone monitoring. See all three on our testosterone therapy page, and read how non-hormonal TRT works for a step-by-step overview.
The process starts with a 5-minute online intake and a $199 video consultation with a physician, which can be credited back with a membership. Your diagnostic panel is drawn by an in-home phlebotomist or at a lab, with results in 7 to 14 days, and a physician walks you through what your testosterone, LH, FSH and estradiol mean. BioCure is physician-led, licensed in 47 states, and does not bill insurance directly, but many patients use HSA or FSA funds with the documentation we provide.
Frequently asked questions
Is clomiphene better than TRT?
Neither is better for everyone. Clomiphene can raise testosterone while preserving fertility in men with secondary hypogonadism, while TRT works regardless of the cause but suppresses sperm production. The right choice depends on your LH and FSH results, your fertility plans and how you respond on follow-up labs.
Is enclomiphene legal in the US in 2026?
Enclomiphene is not FDA-approved, and there is no approved US product. It has been dispensed through compounding pharmacies, but its compounding status has been contested by regulators. Ask your prescriber which pharmacy supplies it and on what legal basis before you start.
Can hCG raise testosterone on its own without TRT?
Yes, if your testes work normally. hCG mimics LH and directly stimulates the testes to make testosterone, and its FDA label includes selected cases of hypogonadotropic hypogonadism in men. It will not help much if the testes themselves are damaged.
Will TRT make me infertile?
TRT suppresses the LH and FSH signals your testes need to make sperm, so sperm counts usually fall. That is why the Endocrine Society and AUA advise against TRT for men trying to conceive. If children are in your plans, discuss SERMs or hCG first.
How do I know if my low testosterone is primary or secondary?
A blood test answers it. Low testosterone with low or normal LH suggests secondary hypogonadism, which often responds to SERMs or hCG. Low testosterone with high LH suggests primary hypogonadism, where TRT is usually the answer.
Raising your own testosterone is a real option, not a supplement-aisle promise, but it only works for the right diagnosis. Longevity is not accidental, it is intentional, and that starts with knowing which kind of low testosterone you have.
Let BioCure Health lead you in the right direction. Call or text us to schedule an introductory call at 754-206-0838. Your future self will thank you.